{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:14:21Z","timestamp":1781165661604,"version":"3.54.1"},"reference-count":31,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.23922\/jarc.2024-039","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:12:52Z","timestamp":1737756772000},"page":"33-40","source":"Crossref","is-referenced-by-count":2,"title":["Metastatic Status and Dissection Effect of Regional\/Extraregional Lymph Nodes in Japanese Patients with Squamous Cell Carcinoma of the Anal Canal: A Multicenter Retrospective Cohort Study"],"prefix":"10.23922","volume":"9","author":[{"given":"Takayuki","family":"Torigoe","sequence":"first","affiliation":[{"name":"Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health"},{"name":"Department of Surgery, Tobata Kyoritsu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Coloproctology Center, Takano Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[{"name":"Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Tokyo Medical and Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73 (1):17-48.","DOI":"10.3322\/caac.21763"},{"key":"2","unstructured":"2. Cummings BJ, Swallow CJ, Ajani JA. Cancer: principles &amp; practice of oncology. 8th ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2008. DeVita VT Jr, Lawrence TS, Rosenberg SA, et al., ed. Cancer of the anal region; p. 1301-14."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Klas JV, Rothenberger DA, Wong WD, et al. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 1999 Apr;85 (8):1686-93.","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer. 2008 Nov;113 (10):2892-900.","DOI":"10.1002\/cncr.23744"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamada K, Saiki Y, Komori K, et al. Characteristics of anal canal cancer in Japan. Cancer Med. 2022 Jul;11 (14):2735-43.","DOI":"10.1002\/cam4.4631"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Daling JR, Weiss NS, Klopfenstein LL, et al. Correlates of homosexual behavior and the incidence of anal cancer. JAMA. 1982 Apr;247 (14):1988-90.","DOI":"10.1001\/jama.247.14.1988"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Peters RK, Mack TM. Patterns of anal carcinoma by gender and marital status in los Angeles County. Br J Cancer. 1983 Nov;48 (5):629-36.","DOI":"10.1038\/bjc.1983.244"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997 Nov;337 (19):1350-8.","DOI":"10.1056\/NEJM199711063371904"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000 Sep;92 (18):1500-10.","DOI":"10.1093\/jnci\/92.18.1500"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000 Mar;342 (11):792-800.","DOI":"10.1056\/NEJM200003163421107"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011 Oct;365 (17):1576-85.","DOI":"10.1056\/NEJMoa1010971"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamada K, Shiraishi K, Takashima A, et al. Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan. Int J Clin Oncol. 2023 Aug;28 (8):990-8.","DOI":"10.1007\/s10147-023-02339-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1993 Jul;36 (7):709-11.","DOI":"10.1007\/BF02238600"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996 Sep;14 (9):2527-39.","DOI":"10.1200\/JCO.1996.14.9.2527"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Borgheresi A, De Muzio F, Agostini A, et al. Lymph nodes evaluation in rectal cancer: where do we stand and future perspective. J Clin Med. 2022 May;11 (9):2599.","DOI":"10.3390\/jcm11092599"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299 (16):1914-21.","DOI":"10.1001\/jama.299.16.1914"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol. 2012 Dec;30 (35):4344-51.","DOI":"10.1200\/JCO.2012.43.8085"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial. Lancet Oncol. 2013;14 (6):516-24.","DOI":"10.1016\/S1470-2045(13)70086-X"},{"key":"19","unstructured":"19. Benson AB, Venook AP, Al-Hawary MM. Anal carcinoma, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023 Jun;21 (6):653-77."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Golia Pernicka JS, Sheedy SP, Ernst RD, et al. Rauch MR staging of anal cancer: what the radiologist needs to know. Abdom Radiol (NY). 2019 Nov;44 (11):3726-39.","DOI":"10.1007\/s00261-019-02020-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jones M, Hruby G, Solomon M, et al. The role of FDG-PET in the initial staging and response assessment of anal cancer: A systematic review and meta-analysis. Ann Surg Oncol. 2015 Oct;22 (11):3574-81.","DOI":"10.1245\/s10434-015-4391-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chulroek T, Kordbacheh H, Wangcharoenrung D, et al. Comparative accuracy of qualitative and quantitative 18F-FDG PET\/CT analysis in detection of lymph node metastasis from anal cancer. Abdom Radiol (NY). 2019 Mar;44 (3):828-35.","DOI":"10.1007\/s00261-019-01907-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant. 2013 Mar;48 (3):452-8.","DOI":"10.1038\/bmt.2012.244"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995 Mar;82 (3):346-51.","DOI":"10.1002\/bjs.1800820321"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ito Y, Hamaguchi T, Takashima A, et al. Definitive S-1\/mitomycin-C chemoradiotherapy for stage II\/III anal canal squamous cell carcinoma: a phase I\/II dose-finding and single-arm confirmatory study (JCOG0903). Int J Clin Oncol. 2023 Aug;28 (8):1063-72.","DOI":"10.1007\/s10147-023-02361-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Damron EP, McDonald J, Rooney MK, et al. Salvage treatment of recurrent or persistent anal squamous cell carcinoma: the role of multi-modality therapy. Clin Colorectal Cancer. 2024 Mar;23 (1):85-94.","DOI":"10.1016\/j.clcc.2023.12.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kitaguchi D, Tsukada Y, Ito M, et al. Survival outcomes following salvage abdominoperineal resection for recurrent and persistent anal squamous cell carcinoma. Eur J Surg Oncol. 2023 Sep;49 (9):106929.","DOI":"10.1016\/j.ejso.2023.05.004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Parkin E, Kallipershad S, Nasser A, et al. Predictors of recurrence following local excision for early-stage anal squamous cell carcinoma. Eur J Surg Oncol. 2023 Nov;49 (11):107093.","DOI":"10.1016\/j.ejso.2023.107093"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Saiki Y, Yamada K, Tanaka M, et al. Prognosis of anal canal adenocarcinoma versus lower rectal adenocarcinoma in Japan: a propensity score matching study. Surg Today. 2022 Mar;52 (3):420-30.","DOI":"10.1007\/s00595-021-02350-1"},{"key":"30","unstructured":"30. Goodman KA, Gollub M, Eng C. AJCC cancer staging system: anus. 9th version. Chicago: American College of Surgeons; 2022."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Janczewski LM, Faski J, Nelson H, et al. Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer. CA Cancer J Clin. 2023 Sep;73 (5):516-23.","DOI":"10.3322\/caac.21780"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:53:59Z","timestamp":1737780839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2024-039","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"article-number":"2024-039"}}